134 related articles for article (PubMed ID: 18158729)
1. The functional evaluation of dendritic cell vaccines based on different hepatitis C virus nonstructural genes.
Tian Y; Zhang HH; Wei L; Du SC; Chen HS; Fei R; Liu F
Viral Immunol; 2007 Dec; 20(4):553-61. PubMed ID: 18158729
[TBL] [Abstract][Full Text] [Related]
2. Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cells.
Echeverria I; Pereboev A; Silva L; Zabaleta A; Riezu-Boj JI; Bes M; Cubero M; Borras-Cuesta F; Lasarte JJ; Esteban JI; Prieto J; Sarobe P
Hepatology; 2011 Jul; 54(1):28-37. PubMed ID: 21452282
[TBL] [Abstract][Full Text] [Related]
3. [Comparative analysis of the immune response to DNA constructions encoding hepatitis C virus nonstructural proteins].
Masalova OV; Lesnova EI; Ivanov AV; Pichugin AV; Permiakova KIu; Smirnova OA; Tynitskaia VL; Ulanova TI; Burkov AN; Kochetkov SN; Ataullakhanov RI; Kushch AA
Vopr Virusol; 2013; 58(2):21-8. PubMed ID: 23785766
[TBL] [Abstract][Full Text] [Related]
4. Priming and stimulation of hepatitis C virus-specific CD4+ and CD8+ T cells against HCV antigens NS4, NS5a or NS5b from HCV-naive individuals: implications for prophylactic vaccine.
Li W; Krishnadas DK; Kumar R; Tyrrell DL; Agrawal B
Int Immunol; 2008 Jan; 20(1):89-104. PubMed ID: 18006878
[TBL] [Abstract][Full Text] [Related]
5. Induction of antigen-specific immune responses in vivo after vaccination with dendritic cells transduced with adenoviral vectors encoding hepatitis C virus NS3.
Xiang M; Eisenbach C; Lupu CM; Ernst E; Stremmel W; Encke J
Viral Immunol; 2006; 19(2):210-9. PubMed ID: 16817764
[TBL] [Abstract][Full Text] [Related]
6. Recombinant adenoviral vector expressing HCV NS4 induces protective immune responses in a mouse model of Vaccinia-HCV virus infection: a dose and route conundrum.
Singh S; Vedi S; Li W; Samrat SK; Kumar R; Agrawal B
Vaccine; 2014 May; 32(23):2712-21. PubMed ID: 24631092
[TBL] [Abstract][Full Text] [Related]
7. Induction of Genotype Cross-Reactive, Hepatitis C Virus-Specific, Cell-Mediated Immunity in DNA-Vaccinated Mice.
Wijesundara DK; Gummow J; Li Y; Yu W; Quah BJ; Ranasinghe C; Torresi J; Gowans EJ; Grubor-Bauk B
J Virol; 2018 Apr; 92(8):. PubMed ID: 29437963
[TBL] [Abstract][Full Text] [Related]
8. A Multiantigenic DNA Vaccine That Induces Broad Hepatitis C Virus-Specific T-Cell Responses in Mice.
Gummow J; Li Y; Yu W; Garrod T; Wijesundara D; Brennan AJ; Mullick R; Voskoboinik I; Grubor-Bauk B; Gowans EJ
J Virol; 2015 Aug; 89(15):7991-8002. PubMed ID: 26018154
[TBL] [Abstract][Full Text] [Related]
9. Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain.
Mikkelsen M; Holst PJ; Bukh J; Thomsen AR; Christensen JP
J Immunol; 2011 Feb; 186(4):2355-64. PubMed ID: 21257961
[TBL] [Abstract][Full Text] [Related]
10. Immunity and protection by adoptive transfer of dendritic cells transfected with hepatitis C NS3/4A mRNA.
Yu H; Babiuk LA; van Drunen Littel-van den Hurk S
Vaccine; 2007 Feb; 25(10):1701-11. PubMed ID: 17240490
[TBL] [Abstract][Full Text] [Related]
11. Monocyte-derived dendritic cells from HCV-infected patients transduced with an adenovirus expressing NS3 are functional when stimulated with the TLR3 ligand poly(I:C).
Echeverría I; Zabaleta A; Silva L; Díaz-Valdés N; Riezu-Boj JI; Lasarte JJ; Borrás-Cuesta F; Civeira MP; Prieto J; Sarobe P
J Viral Hepat; 2008 Nov; 15(11):782-9. PubMed ID: 18637068
[TBL] [Abstract][Full Text] [Related]
12. Vaccination against hepatitis C virus with dendritic cells transduced with an adenovirus encoding NS3 protein.
Zabaleta A; Llopiz D; Arribillaga L; Silva L; Riezu-Boj JI; Lasarte JJ; Borrás-Cuesta F; Prieto J; Sarobe P
Mol Ther; 2008 Jan; 16(1):210-7. PubMed ID: 17923840
[TBL] [Abstract][Full Text] [Related]
13. Induction of primary human T cell responses against hepatitis C virus-derived antigens NS3 or core by autologous dendritic cells expressing hepatitis C virus antigens: potential for vaccine and immunotherapy.
Li W; Krishnadas DK; Li J; Tyrrell DL; Agrawal B
J Immunol; 2006 May; 176(10):6065-75. PubMed ID: 16670315
[TBL] [Abstract][Full Text] [Related]
14. Strong HCV NS3/4a, NS4b, NS5a, NS5b-specific cellular immune responses induced in Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine.
Latimer B; Toporovski R; Yan J; Pankhong P; Morrow MP; Khan AS; Sardesai NY; Welles SL; Jacobson JM; Weiner DB; Kutzler MA
Hum Vaccin Immunother; 2014; 10(8):2357-65. PubMed ID: 25424943
[TBL] [Abstract][Full Text] [Related]
15. Strategies for loading dendritic cells with hepatitis C NS5a antigen and inducing protective immunity.
Yu H; Babiuk LA; van Drunen Littel-van den Hurk S
J Viral Hepat; 2008 Jun; 15(6):459-70. PubMed ID: 18221298
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus polyprotein vaccine formulations capable of inducing broad antibody and cellular immune responses.
Vajdy M; Selby M; Medina-Selby A; Coit D; Hall J; Tandeske L; Chien D; Hu C; Rosa D; Singh M; Kazzaz J; Nguyen S; Coates S; Ng P; Abrignani S; Lin YL; Houghton M; O'Hagan DT
J Gen Virol; 2006 Aug; 87(Pt 8):2253-2262. PubMed ID: 16847121
[TBL] [Abstract][Full Text] [Related]
17. DNA immunization with hepatitis C virus (HCV) polycistronic genes or immunization by HCV DNA priming-recombinant canarypox virus boosting induces immune responses and protection from recombinant HCV-vaccinia virus infection in HLA-A2.1-transgenic mice.
Pancholi P; Perkus M; Tricoche N; Liu Q; Prince AM
J Virol; 2003 Jan; 77(1):382-90. PubMed ID: 12477843
[TBL] [Abstract][Full Text] [Related]
18. Priming with two DNA vaccines expressing hepatitis C virus NS3 protein targeting dendritic cells elicits superior heterologous protective potential in mice.
Guan J; Deng Y; Chen H; Yin X; Yang Y; Tan W
Arch Virol; 2015 Oct; 160(10):2517-24. PubMed ID: 26215441
[TBL] [Abstract][Full Text] [Related]
19. Cellular immune responses and occult infection in seronegative heterosexual partners of chronic hepatitis C patients.
Roque-Cuéllar MC; Sánchez B; García-Lozano JR; Praena-Fernández JM; Núñez-Roldán A; Aguilar-Reina J
J Viral Hepat; 2011 Oct; 18(10):e541-9. PubMed ID: 21914075
[TBL] [Abstract][Full Text] [Related]
20. Development of a dendritic cell vaccine encoding multiple cytotoxic T lymphocyte epitopes targeting hepatitis C virus.
Zhou Y; Zhao F; Chen L; Ma L; Wang Y; He Y; Ma Z; Liu H; Guo Y; Zhang Y; Yao Z; Hao C; Jia Z
Int J Mol Med; 2013 Oct; 32(4):901-9. PubMed ID: 23934073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
